◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › D › DMP

Dermapharm Holding SE (DMP) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-08-16

Dermapharm Holding SE (DMP) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Grünwald, Germany with about 3,503 employees. Its market capitalization is roughly €2 billion. In the fiscal year ended 2025-12-31, DMP reported €1.2B in revenue and €132M in net income.

Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China.

Interactive charts & full statements →

DMP Revenue & Earnings History — Annual Income Statement

Income statement	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Total Revenue	€1.2B	€1.2B	€1.1B	€1.0B
Gross Profit	€783M	€767M	€719M	€661M
Operating Income (EBIT)	€227M	€215M	€180M	€242M
Net Income	€132M	€114M	€62M	€134M

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

DMP Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Total Revenue	€306M	€296M	€295M	€272M	€302M
Gross Profit	€208M	€204M	€196M	€184M	€199M
Operating Income (EBIT)	€71M	€58M	€65M	€44M	€60M
Net Income	€45M	€37M	€41M	€21M	€33M

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

DMP Free Cash Flow History

Cash flow	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Dividends Paid	(€48M)	(€47M)	(€56M)	(€117M)	—

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

DMP Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Dividends Paid	—	€0M	—	—	—	€0M

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

DMP Balance Sheet History

Balance sheet	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Assets	€2.2B	€2.1B	€2.2B	€1.4B	—
Total Liabilities	€1.5B	€1.5B	€1.6B	€880M	—

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive DMP viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

PBH · Prestige Consumer Healthcare Inc. — $2 billion
2561 · VISEN Pharmaceuticals — $2 billion
BHC · Bausch Health Companies Inc. — $2 billion
2633 · Jacobson Pharma Corporation Limited — $2 billion
PRGO · Perrigo Company plc — $2 billion
ANIP · ANI Pharmaceuticals, Inc. — $2 billion
TRLV · Trulieve Cannabis Corp. — $2 billion
ETON · Eton Pharmaceuticals, Inc. — $2 billion

← DMO All “D” companies DMRA →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.